- Home
- BKSY vs CRDF Comparison
BKSY vs CRDF Comparison
Compare BKSY & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKSY
- CRDF
- Stock Information
- Founded
- BKSY 2013
- CRDF 1999
- Country
- BKSY United States
- CRDF United States
- Employees
- BKSY N/A
- CRDF N/A
- Industry
- BKSY Radio And Television Broadcasting And Communications Equipment
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BKSY Technology
- CRDF Health Care
- Exchange
- BKSY Nasdaq
- CRDF Nasdaq
- Market Cap
- BKSY 303.5M
- CRDF 288.7M
- IPO Year
- BKSY N/A
- CRDF N/A
- Fundamental
- Price
- BKSY $6.62
- CRDF $2.71
- Analyst Decision
- BKSY Strong Buy
- CRDF Strong Buy
- Analyst Count
- BKSY 5
- CRDF 4
- Target Price
- BKSY $21.80
- CRDF $12.00
- AVG Volume (30 Days)
- BKSY 1.1M
- CRDF 1.1M
- Earning Date
- BKSY 03-06-2025
- CRDF 05-01-2025
- Dividend Yield
- BKSY N/A
- CRDF N/A
- EPS Growth
- BKSY N/A
- CRDF N/A
- EPS
- BKSY N/A
- CRDF N/A
- Revenue
- BKSY $102,093,000.00
- CRDF $683,000.00
- Revenue This Year
- BKSY $33.53
- CRDF N/A
- Revenue Next Year
- BKSY $33.06
- CRDF N/A
- P/E Ratio
- BKSY N/A
- CRDF N/A
- Revenue Growth
- BKSY 8.04
- CRDF 39.96
- 52 Week Low
- BKSY $3.86
- CRDF $2.01
- 52 Week High
- BKSY $21.92
- CRDF $6.38
- Technical
- Relative Strength Index (RSI)
- BKSY 27.49
- CRDF 27.52
- Support Level
- BKSY $7.29
- CRDF $3.65
- Resistance Level
- BKSY $8.27
- CRDF $3.88
- Average True Range (ATR)
- BKSY 0.59
- CRDF 0.18
- MACD
- BKSY -0.02
- CRDF -0.10
- Stochastic Oscillator
- BKSY 2.37
- CRDF 2.04
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").